C
ICL Group Ltd
ICL
$6.07
$0.020.33%
C
Hold
2/20/2025Upgraded
ICL Group Ltd (ICL) was upgraded to C from C- on 2/20/2025 due to an increase in the total return index, volatility index and efficiency index.
ICL Group Ltd (ICL) was upgraded to C from C- on 2/20/2025 due to an increase in the total return index, volatility index and efficiency index.
C
Hold
1/22/2025Upgraded
ICL Group Ltd (ICL) was upgraded to C- from D+ on 1/22/2025 due to an increase in the volatility index and total return index.
ICL Group Ltd (ICL) was upgraded to C- from D+ on 1/22/2025 due to an increase in the volatility index and total return index.
D
Sell
1/7/2025Downgrade
ICL Group Ltd (ICL) was downgraded to D+ from C- on 1/7/2025 due to a decline in the volatility index and valuation index.
ICL Group Ltd (ICL) was downgraded to D+ from C- on 1/7/2025 due to a decline in the volatility index and valuation index.
C
Hold
12/11/2024Upgraded
ICL Group Ltd (ICL) was upgraded to C- from D+ on 12/11/2024 due to an increase in the total return index and volatility index.
ICL Group Ltd (ICL) was upgraded to C- from D+ on 12/11/2024 due to an increase in the total return index and volatility index.
D
Sell
11/19/2024Downgrade
ICL Group Ltd (ICL) was downgraded to D+ from C- on 11/19/2024 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.0892 to $0.0876.
ICL Group Ltd (ICL) was downgraded to D+ from C- on 11/19/2024 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.0892 to $0.0876.
C
Hold
1/16/2024Downgrade
ICL Group Ltd (ICL) was downgraded to C- from C on 1/16/2024 due to a substantial decline in the growth index, volatility index and total return index. EBIT declined 24.33% from $300M to $227M, earnings per share declined from $0.12 to $0.1063, and total revenue declined 1.27% from $1.89B to $1.86B.
ICL Group Ltd (ICL) was downgraded to C- from C on 1/16/2024 due to a substantial decline in the growth index, volatility index and total return index. EBIT declined 24.33% from $300M to $227M, earnings per share declined from $0.12 to $0.1063, and total revenue declined 1.27% from $1.89B to $1.86B.
C
Hold
6/8/2023Downgrade
ICL Group Ltd (ICL) was downgraded to C from C+ on 6/8/2023 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.47 to 0.53, and the quick ratio declined from 0.9 to 0.85.
ICL Group Ltd (ICL) was downgraded to C from C+ on 6/8/2023 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.47 to 0.53, and the quick ratio declined from 0.9 to 0.85.
C
Hold
3/28/2023Downgrade
ICL Group Ltd (ICL) was downgraded to C+ from B- on 3/28/2023 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from $0.49 to $0.2508, EBIT declined 41.39% from $935M to $548M, and operating cash flow declined 22.94% from $606M to $467M.
ICL Group Ltd (ICL) was downgraded to C+ from B- on 3/28/2023 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from $0.49 to $0.2508, EBIT declined 41.39% from $935M to $548M, and operating cash flow declined 22.94% from $606M to $467M.
B
Buy
1/19/2023Upgraded
ICL Group Ltd (ICL) was upgraded to B- from C+ on 1/19/2023 due to an increase in the total return index.
ICL Group Ltd (ICL) was upgraded to B- from C+ on 1/19/2023 due to an increase in the total return index.
C
Hold
12/22/2022Downgrade
ICL Group Ltd (ICL) was downgraded to C+ from B- on 12/22/2022 due to a decline in the growth index, total return index and volatility index. EBIT declined 17.91% from $1.14B to $935M, total revenue declined 12.53% from $2.88B to $2.52B, and operating cash flow declined 3.35% from $627M to $606M.
ICL Group Ltd (ICL) was downgraded to C+ from B- on 12/22/2022 due to a decline in the growth index, total return index and volatility index. EBIT declined 17.91% from $1.14B to $935M, total revenue declined 12.53% from $2.88B to $2.52B, and operating cash flow declined 3.35% from $627M to $606M.
B
Buy
7/18/2022Downgrade
ICL Group Ltd (ICL) was downgraded to B- from B on 7/18/2022 due to a significant decline in the total return index and volatility index.
ICL Group Ltd (ICL) was downgraded to B- from B on 7/18/2022 due to a significant decline in the total return index and volatility index.
B
Buy
6/2/2022Downgrade
ICL Group Ltd (ICL) was downgraded to B from B+ on 6/2/2022 due to a decline in the total return index, volatility index and valuation index.
ICL Group Ltd (ICL) was downgraded to B from B+ on 6/2/2022 due to a decline in the total return index, volatility index and valuation index.
B
Buy
5/16/2022Upgraded
ICL Group Ltd (ICL) was upgraded to B+ from B on 5/16/2022 due to a major increase in the valuation index, total return index and solvency index. The quick ratio increased from 0.86 to 0.9, and debt to equity declined from 0.6 to 0.57.
ICL Group Ltd (ICL) was upgraded to B+ from B on 5/16/2022 due to a major increase in the valuation index, total return index and solvency index. The quick ratio increased from 0.86 to 0.9, and debt to equity declined from 0.6 to 0.57.
B
Buy
11/8/2021Upgraded
ICL Group Ltd (ICL) was upgraded to B from B- on 11/8/2021 due to a substantial increase in the growth index, total return index and efficiency index. Net income increased 60.71% from $140M to $225M, earnings per share increased from $0.1092 to $0.17, and EBIT increased 24.69% from $243M to $303M.
ICL Group Ltd (ICL) was upgraded to B from B- on 11/8/2021 due to a substantial increase in the growth index, total return index and efficiency index. Net income increased 60.71% from $140M to $225M, earnings per share increased from $0.1092 to $0.17, and EBIT increased 24.69% from $243M to $303M.
B
Buy
10/18/2021Upgraded
ICL Group Ltd (ICL) was upgraded to B- from C+ on 10/18/2021 due to an increase in the volatility index and total return index.
ICL Group Ltd (ICL) was upgraded to B- from C+ on 10/18/2021 due to an increase in the volatility index and total return index.
C
Hold
10/1/2021Downgrade
ICL Group Ltd (ICL) was downgraded to C+ from B- on 10/1/2021 due to a decline in the valuation index, volatility index and dividend index.
ICL Group Ltd (ICL) was downgraded to C+ from B- on 10/1/2021 due to a decline in the valuation index, volatility index and dividend index.
B
Buy
9/13/2021Upgraded
ICL Group Ltd (ICL) was upgraded to B- from C+ on 9/13/2021 due to an increase in the volatility index, valuation index and dividend index.
ICL Group Ltd (ICL) was upgraded to B- from C+ on 9/13/2021 due to an increase in the volatility index, valuation index and dividend index.
C
Hold
8/19/2021Downgrade
ICL Group Ltd (ICL) was downgraded to C+ from B- on 8/19/2021 due to a decline in the total return index and dividend index.
ICL Group Ltd (ICL) was downgraded to C+ from B- on 8/19/2021 due to a decline in the total return index and dividend index.
B
Buy
8/4/2021Upgraded
ICL Group Ltd (ICL) was upgraded to B- from C+ on 8/4/2021 due to a large increase in the total return index.
ICL Group Ltd (ICL) was upgraded to B- from C+ on 8/4/2021 due to a large increase in the total return index.
C
Hold
7/30/2021Upgraded
ICL Group Ltd (ICL) was upgraded to C+ from C on 7/30/2021 due to a significant increase in the valuation index, growth index and total return index. EBIT increased 31.35% from $185M to $243M, operating cash flow increased 17.48% from $206M to $242M, and total revenue increased 7.09% from $1.51B to $1.62B.
ICL Group Ltd (ICL) was upgraded to C+ from C on 7/30/2021 due to a significant increase in the valuation index, growth index and total return index. EBIT increased 31.35% from $185M to $243M, operating cash flow increased 17.48% from $206M to $242M, and total revenue increased 7.09% from $1.51B to $1.62B.
C
Hold
3/4/2021Upgraded
ICL Group Ltd (ICL) was upgraded to C from C- on 3/4/2021 due to a major increase in the total return index, growth index and solvency index. EBIT increased 119% from $100M to $219M, operating cash flow increased 27.09% from $203M to $258M, and earnings per share increased from $0.04 to $0.05.
ICL Group Ltd (ICL) was upgraded to C from C- on 3/4/2021 due to a major increase in the total return index, growth index and solvency index. EBIT increased 119% from $100M to $219M, operating cash flow increased 27.09% from $203M to $258M, and earnings per share increased from $0.04 to $0.05.
C
Hold
11/16/2020Downgrade
ICL Group Ltd (ICL) was downgraded to C- from C on 11/16/2020 due to a decline in the valuation index, efficiency index and dividend index. Total capital declined 0.3% from $6.7B to $6.68B.
ICL Group Ltd (ICL) was downgraded to C- from C on 11/16/2020 due to a decline in the valuation index, efficiency index and dividend index. Total capital declined 0.3% from $6.7B to $6.68B.
C
Hold
11/9/2020Upgraded
ICL Group Ltd (ICL) was upgraded to C from C- on 11/9/2020 due to a noticeable increase in the volatility index, total return index and dividend index.
ICL Group Ltd (ICL) was upgraded to C from C- on 11/9/2020 due to a noticeable increase in the volatility index, total return index and dividend index.
C
Hold
7/23/2020Upgraded
ICL Group Ltd (ICL) was upgraded to C- from D+ on 7/23/2020 due to an increase in the volatility index and total return index.
ICL Group Ltd (ICL) was upgraded to C- from D+ on 7/23/2020 due to an increase in the volatility index and total return index.
D
Sell
7/8/2020Downgrade
ICL Group Ltd (ICL) was downgraded to D+ from C- on 7/8/2020 due to a decline in the volatility index.
ICL Group Ltd (ICL) was downgraded to D+ from C- on 7/8/2020 due to a decline in the volatility index.
C
Hold
6/22/2020Upgraded
ICL Group Ltd (ICL) was upgraded to C- from D+ on 6/22/2020 due to a significant increase in the growth index, volatility index and dividend index. EBIT increased 277.14% from $35M to $132M, earnings per share increased from $0.0375 to $0.0469, and total revenue increased 19.26% from $1.11B to $1.32B.
ICL Group Ltd (ICL) was upgraded to C- from D+ on 6/22/2020 due to a significant increase in the growth index, volatility index and dividend index. EBIT increased 277.14% from $35M to $132M, earnings per share increased from $0.0375 to $0.0469, and total revenue increased 19.26% from $1.11B to $1.32B.
D
Sell
4/20/2020Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to D+ from C- on 4/20/2020 due to a decline in the total return index, volatility index and solvency index.
Israel Chemicals Ltd. (ICL) was downgraded to D+ from C- on 4/20/2020 due to a decline in the total return index, volatility index and solvency index.
C
Hold
3/12/2020Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to C- from C on 3/12/2020 due to a major decline in the growth index, total return index and volatility index. EBIT declined 82.59% from $201M to $35M, earnings per share declined from $0.1 to $0.0375, and operating cash flow declined 42.39% from $368M to $212M.
Israel Chemicals Ltd. (ICL) was downgraded to C- from C on 3/12/2020 due to a major decline in the growth index, total return index and volatility index. EBIT declined 82.59% from $201M to $35M, earnings per share declined from $0.1 to $0.0375, and operating cash flow declined 42.39% from $368M to $212M.
C
Hold
1/24/2020Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to C from C+ on 1/24/2020 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.85 to 0.84.
Israel Chemicals Ltd. (ICL) was downgraded to C from C+ on 1/24/2020 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.85 to 0.84.
C
Hold
10/21/2019Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to C+ from B- on 10/21/2019 due to a noticeable decline in the volatility index, total return index and growth index.
Israel Chemicals Ltd. (ICL) was downgraded to C+ from B- on 10/21/2019 due to a noticeable decline in the volatility index, total return index and growth index.
B
Buy
5/9/2019Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to B- from B on 5/9/2019 due to a substantial decline in the valuation index, growth index and total return index. Operating cash flow declined 22.77% from $224M to $173M.
Israel Chemicals Ltd. (ICL) was downgraded to B- from B on 5/9/2019 due to a substantial decline in the valuation index, growth index and total return index. Operating cash flow declined 22.77% from $224M to $173M.
B
Buy
11/6/2018Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to B from B- on 11/6/2018 due to an increase in the total return index, growth index and volatility index. Earnings per share increased from $0.0791 to $0.1, operating cash flow increased 19.51% from $164M to $196M, and EBIT increased 4.26% from $188M to $196M.
Israel Chemicals Ltd. (ICL) was upgraded to B from B- on 11/6/2018 due to an increase in the total return index, growth index and volatility index. Earnings per share increased from $0.0791 to $0.1, operating cash flow increased 19.51% from $164M to $196M, and EBIT increased 4.26% from $188M to $196M.
B
Buy
8/9/2018Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to B- from C+ on 8/9/2018 due to an increase in the volatility index, total return index and solvency index. Debt to equity declined from 0.83 to 0.67.
Israel Chemicals Ltd. (ICL) was upgraded to B- from C+ on 8/9/2018 due to an increase in the volatility index, total return index and solvency index. Debt to equity declined from 0.83 to 0.67.
C
Hold
5/24/2018Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to C+ from C on 5/24/2018 due to a significant increase in the valuation index, total return index and volatility index.
Israel Chemicals Ltd. (ICL) was upgraded to C+ from C on 5/24/2018 due to a significant increase in the valuation index, total return index and volatility index.
C
Hold
3/7/2018Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to C from C- on 3/7/2018 due to an increase in the total return index.
Israel Chemicals Ltd. (ICL) was upgraded to C from C- on 3/7/2018 due to an increase in the total return index.
C
Hold
2/9/2018Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to C- from C on 2/9/2018 due to a decline in the total return index, growth index and volatility index.
Israel Chemicals Ltd. (ICL) was downgraded to C- from C on 2/9/2018 due to a decline in the total return index, growth index and volatility index.
C
Hold
11/13/2017Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to C from D+ on 11/13/2017 due to a significant increase in the valuation index, growth index and efficiency index. Net income increased 47.37% from $57M to $84M, earnings per share increased from $0.0447 to $0.0657, and EBIT increased 34.5% from $148.7M to $200M.
Israel Chemicals Ltd. (ICL) was upgraded to C from D+ on 11/13/2017 due to a significant increase in the valuation index, growth index and efficiency index. Net income increased 47.37% from $57M to $84M, earnings per share increased from $0.0447 to $0.0657, and EBIT increased 34.5% from $148.7M to $200M.
D
Sell
10/4/2017Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to D+ from C- on 10/4/2017 due to a decline in the growth index, efficiency index and solvency index. Net income declined 16.18% from $68M to $57M, earnings per share declined from $0.053 to $0.0447, and the quick ratio declined from 0.64 to 0.6.
Israel Chemicals Ltd. (ICL) was downgraded to D+ from C- on 10/4/2017 due to a decline in the growth index, efficiency index and solvency index. Net income declined 16.18% from $68M to $57M, earnings per share declined from $0.053 to $0.0447, and the quick ratio declined from 0.64 to 0.6.
C
Hold
6/23/2017Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to C- from D+ on 6/23/2017 due to an increase in the volatility index and total return index.
Israel Chemicals Ltd. (ICL) was upgraded to C- from D+ on 6/23/2017 due to an increase in the volatility index and total return index.
D
Sell
5/12/2017Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to D+ from C- on 5/12/2017 due to a decline in the total return index, efficiency index and dividend index.
Israel Chemicals Ltd. (ICL) was downgraded to D+ from C- on 5/12/2017 due to a decline in the total return index, efficiency index and dividend index.
C
Hold
2/27/2017Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to C- from D+ on 2/27/2017 due to a noticeable increase in the total return index and volatility index.
Israel Chemicals Ltd. (ICL) was upgraded to C- from D+ on 2/27/2017 due to a noticeable increase in the total return index and volatility index.
D
Sell
8/12/2016Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to D+ from D on 8/12/2016 due to a noticeable increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.05 to $0.09, EBIT increased 20% from $115M to $138M, and total revenue increased 8.85% from $1.27B to $1.38B.
Israel Chemicals Ltd. (ICL) was upgraded to D+ from D on 8/12/2016 due to a noticeable increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.05 to $0.09, EBIT increased 20% from $115M to $138M, and total revenue increased 8.85% from $1.27B to $1.38B.
D
Sell
5/20/2016Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to D from D+ on 5/20/2016 due to a large decline in the valuation index, growth index and efficiency index. EBIT declined 48.89% from $225M to $115M, earnings per share declined from $0.0744 to $0.05, and net income declined 31.25% from $96M to $66M.
Israel Chemicals Ltd. (ICL) was downgraded to D from D+ on 5/20/2016 due to a large decline in the valuation index, growth index and efficiency index. EBIT declined 48.89% from $225M to $115M, earnings per share declined from $0.0744 to $0.05, and net income declined 31.25% from $96M to $66M.
D
Sell
5/16/2016Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to D+ from D on 5/16/2016 due to an increase in the total return index and volatility index.
Israel Chemicals Ltd. (ICL) was upgraded to D+ from D on 5/16/2016 due to an increase in the total return index and volatility index.
D
Sell
3/17/2016Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to D from D+ on 3/17/2016 due to a decline in the growth index, efficiency index and dividend index. Operating cash flow declined 53.23% from $124M to $58M, earnings per share declined from $0.0951 to $0.0744, and net income declined 20.66% from $121M to $96M.
Israel Chemicals Ltd. (ICL) was downgraded to D from D+ on 3/17/2016 due to a decline in the growth index, efficiency index and dividend index. Operating cash flow declined 53.23% from $124M to $58M, earnings per share declined from $0.0951 to $0.0744, and net income declined 20.66% from $121M to $96M.
D
Sell
3/11/2016Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to D+ from C on 3/11/2016 due to a substantial decline in the volatility index, total return index and valuation index.
Israel Chemicals Ltd. (ICL) was downgraded to D+ from C on 3/11/2016 due to a substantial decline in the volatility index, total return index and valuation index.
C
Hold
1/25/2016Downgrade
Israel Chemicals Ltd. (ICL) was downgraded to C from C+ on 1/25/2016 due to a decline in the total return index.
Israel Chemicals Ltd. (ICL) was downgraded to C from C+ on 1/25/2016 due to a decline in the total return index.
C
Hold
12/14/2015Upgraded
Israel Chemicals Ltd. (ICL) was upgraded to C+ from C on 12/14/2015 due to a substantial increase in the valuation index, growth index and dividend index. EBIT increased 116.67% from $102M to $221M, earnings per share increased from $0.059 to $0.0951, and total revenue increased 15.3% from $1.2B to $1.38B.
Israel Chemicals Ltd. (ICL) was upgraded to C+ from C on 12/14/2015 due to a substantial increase in the valuation index, growth index and dividend index. EBIT increased 116.67% from $102M to $221M, earnings per share increased from $0.059 to $0.0951, and total revenue increased 15.3% from $1.2B to $1.38B.
C
Hold
8/11/2014Downgrade
Israel Chemicals Ltd. (ISCHF) was downgraded to C from C+ on 8/11/2014 due to a major decline in the growth index, valuation index and dividend index. Earnings per share declined from $0.103 to $0.053, operating cash flow declined 28.61% from $167.34M to $119.47M, and EBIT declined 6.79% from $243.25M to $226.75M.
Israel Chemicals Ltd. (ISCHF) was downgraded to C from C+ on 8/11/2014 due to a major decline in the growth index, valuation index and dividend index. Earnings per share declined from $0.103 to $0.053, operating cash flow declined 28.61% from $167.34M to $119.47M, and EBIT declined 6.79% from $243.25M to $226.75M.
C
Hold
5/22/2014Upgraded
Israel Chemicals Ltd. (ISCHF) was upgraded to C+ from C on 5/22/2014 due to a noticeable increase in the growth index, dividend index and total return index. EBIT increased 74.34% from $139.53M to $243.25M, operating cash flow increased 44.61% from $115.72M to $167.34M, and total revenue increased 13.88% from $1.42B to $1.61B.
Israel Chemicals Ltd. (ISCHF) was upgraded to C+ from C on 5/22/2014 due to a noticeable increase in the growth index, dividend index and total return index. EBIT increased 74.34% from $139.53M to $243.25M, operating cash flow increased 44.61% from $115.72M to $167.34M, and total revenue increased 13.88% from $1.42B to $1.61B.
NYSE
03/06/2025 4:00PM Eastern
Quotes delayed
